Sisätautien yksikkö
Department of Internal Medicine

Julkaisut 1999
Publications 1999

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Balkau B et al. Fasting blood glucose and risk of cardiovascular disease.
2 Bendel S et al. Similar effect of revascularization on technetium-99m sestamibi and 15-(p-iodophenyl)pentadecanoic acid uptake in myocardial infarction patients.
3 Camastra S et al. Effect of obesity and insulin resistance on resting and glucose-induced thermogenesis in man.
4 Dickstein K et al. Comparison of the effects of Losartan and Captopril on mortality in patients after acute myocardial infarction: The OPTIMAAL Trial Design.
5 Erkkilä AT et al. Dietary associates of serum total, LDL, and HDL cholesterol and triglycerides in patients with coronary heart disease.
6 Erkkilä AT et al. Diet in relation to socioeconomic status in patients with coronary heart disease.
7 Folláth F et al. Dose-ranging and safety with intravenous levosimendan in low-output heart failure: experience in three pilot studies and outline of the levosimendan infusion versus dobutamine (LIDO) trial.
8 Haffner SM et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes of impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
9 Haffner SM et al. Is leptin concentration associated with the insulin resistance syndrome in nondiabetic men?
10 Harjola V-P et al. Oral levosimendan improves cardiac function and hemodynamics in patients with severe congestive heart failure.
11 Hedman AE, Hartikainen JEK. Has non-linear analysis of heart rate variability any practical value?
12 Heikkinen S et al. Hexokinase II-deficient mice: prenatal death of homozygotes without disturbances in glucose tolerance in heterozygotes.
13 Heinonen P et al. Identification of a three-amino acid deletion in the alfa2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects.
14 Herman WH et al. Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes: findings from the Scandinavian Simvastatin Survival Study.
15 Hosszúfalusi N et al. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men.
16 Iozzo P et al. Independent influence of age on basal insulin secretion in nondiabetic humans.
17 Jääskeläinen P et al. The cardiac troponin I gene is not associated with hypertrophic cardiomyopathy in patients from Eastern Finland.
18 Kaaja R et al. Evidence of a state of increased insulin resistance in preeclampsia.
19 Keen H et al. Reducing the burden of diabetes: managing cardiovascular disease.
20 Kekäläinen P. Insulin Resistance and Its Association with Type 2 Diabetes, Cardiovascular Risk Factors and Atherosclerosis.
21 Kekäläinen P et al. Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes.
22 Kemppainen T et al. Osteoporosis in adult patients with celiac disease.
23 Kemppainen T et al. Bone recovery after a gluten-free diet: a 5-year follow-up study.
24 Kiviniemi MS et al. Complications related to permanent pacemaker therapy.
25 Koikkalainen M et al. Difficulties in changing the diet in relation to dietary fat intake among patients with coronary heart disease.
26 Koivula I. Pneumonia in the Elderly. Risk Factors, Clinical Efficacy of Pneumococcal Vaccine and Long-term Prognosis.
27 Kuikka JT et al. Transit time heterogeneity of bolus flow through the heart and lungs in patients with left-to-right intracardiac shunt.
28 Kuikka JT et al. Heterogeneity of myocardial blood flow in man.
29 Kuusisto J et al. Sarkomeerin geenimutaatiot - hypertrofisen kardiomyopatian syy.
30 Kuusisto J et al. Insulin resistance syndrome and Alzheimer's disease: the summary of Finnish studies.
31 Kuusisto J, Laakso M. Prandial glucose regulation and cardiovascular disease in Type 2 diabetes.
32 Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes.
33 Laakso M. Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes.
34 Laakso M. Benefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK Prospective Diabetes Study.
35 Laakso M. Hyperglycaemia as a risk factor for cardiovascular disease.
36 Laitinen M. Gene Transfer to the Arterial Wall-Preclinical and Clinical Studies.
37 Laitinen T et al. Sympathovagal balance is major determinant of short-term blood pressure variability in healthy subjects.
38 Laitinen T et al. Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects.
39 Laivuori HM et al. Short-term metabolic effects of isradipine and metoprolol in pre-eclampsia.
40 Lehto S et al. Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy.
41 Lempiäinen P et al. Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men.
42 Louheranta AM et al. A high-trans fatty acid diet and insulin sensitivity in young healthy women.
43 Loukola A et al. Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer.
44 Malkki A-M. The Human Hexokinase II Gene. Structure, Regulation and Role in Type 2 Diabetes.
45 MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF).
46 Miettinen H et al. Trends in the treatment of patients with myocardial infarction and coronary revascularization procedures in Finland during 1986-92: the FINMONICA Myocardial Infarction Register Study.
47 Mykkänen L. Verenpainetaudin hoito aikuistyypin diabeetikoilla.
48 Mykkänen L et al. LDL size and risk of coronary heart disease in elderly men and women.
49 Mähönen M et al. The validity of the routine mortality statistics on coronary heart disease in Finland: comparison with the FINMONICA MI register data for the years 1983-1992.
50 Newby LK, for the SYMPHONY Steering Committee. Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: study desing of the Sibrafiban versus aspirin to Yield Maximun Protection from ischemic heart events post-acute...
51 Niskanen L et al. Hyperglykemian lääkehoito ja aikuistyypin diabeteksen ennuste.
52 Nousiainen T. Cardiovascular and Neurohumoral Effects of Anthracycline Chemotherapy .
53 Nousiainen T et al. Natriuretic peptides as markers of cardiotoxicity during doxorubicin treatment for non-Hodgkin's lymphoma.
54 Nousiainen T et al. QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin's lymphoma.
55 Näslund U et al. The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial: results with and without the end-point committee's final decision on end-points.
56 Overmyer M et al. Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue.
57 Overmyer M et al. Astrogliosis and the ApoE genotype: an immunohistochemical study of postmortem human brain tissue.
58 Pajukanta P et al. Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol, and apolipoprotein B levels.
59 Pakkanen TM et al. Enhanced plasma cholesterol lowering effect of retrovirus-mediated LDL receptor gene transfer to WHHL rabbit liver after improved surgical technique and stimulation of hepatocyte proliferation by combined partial liver res...
60 Penttilä HJ et al. Myocardial metabolism and hemodynamics during coronary surgery without cardiopulmonary bypass.
61 Penttilä K et al. Myoglobin, creatine kinase MB, troponin T, and troponin I - rapid bedside assays in patients with acute chest pain.
62 Poutiainen A-M et al. Prevalence and natural course of ectopic atrial tachycardia.
63 Pulkkinen A et al. The codon 64 polymorphism of the beta3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients.
64 Pyörälä K. Valtimotaudin vaaran yksilöllinen arvioiminen.
65 Pyörälä K. Type 2 diabetic subjects without prior myocardial infarction are at the same risk of coronary events as non-diabetic subjects with prior myocardial infarction.
66 Pyörälä K. Secondary prevention of coronary heart disease in diabetes: a subgroup analysis of ot the Scandinavian simvastatin survival study (4S).
67 Rissanen J. Candidate Genes for Type 2 Diabetes in Finns. Studies on the Glucokinase, Hepatocyte Nuclear Factors-1alfa and -4alfa, Sulfonylurea Receptor-1, beta3-Adrenergic Receptor, Fatty Acid Binding Protein-2 and Glycogen Synthase Genes.
68 Ristikankare M et al. Is routinely given conscious sedation of benefit during colonoscopy?
69 Sivenius J et al. Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age.
70 Sivenius J et al. Antiplatelet treatment does not reduce the severity of subsequent stroke.
71 Sokka T. Extensive Use of Antirheumatic Drugs Improves Long-Term Outcomes in Patients with Rheumatoid Arthritis.
72 Sokka T et al. Ten-year radiographic and functional outcome of "sawtooth" treated rheumatoid arthritis patients.
73 Steiner G et al. Baseline characteristics of the study population in the Diabetes Atherosclerosis Intervention Study (DAIS).
74 The DECODE study group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria.
75 The DECODE-study group on behalf of the European Diabetes Epidemiology Group. Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies.
76 Tikanoja T et al. Simultaneous hypertrophic cardiomyopathy and ventricular septal defect in children.
77 Turpeinen AK et al. Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance Studies with PET and 14(R, S)-[18F]Fluoro-6-Thia-Heptadecanoic acid.
78 Uusimaa P et al. Plasma vasoactive peptides after acute myocardial infarction in relation to left ventricular dysfunction.
79 Valve R et al. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women.
80 Vanhanen M et al. Type-2 diabetes and cognitive function in a non-demented population.
81 Ylitalo K et al. Vasoactive peptide release in relation to hemodynamic and metabolic changes during rapid ventricular pacing.

Sisätautien yksikkö Department of Internal Medicine
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008